Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IDXX | Common Stock | Options Exercise | $452K | +2.19K | +250.8% | $206.62 | 3.06K | May 4, 2023 | Direct | |
transaction | IDXX | Common Stock | Sale | -$1.03M | -2.19K | -71.49% | $469.02 | 872 | May 4, 2023 | Direct | F1 |
transaction | IDXX | Common Stock | Gift | $0 | -500 | -5.77% | $0.00 | 8.17K | May 4, 2023 | By Sophie V. Vandebroek Revocable Trust |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IDXX | Non-Qualified Stock Option (right-to-buy) | Options Exercise | -2.19K | -100% | 0 | May 4, 2023 | Common Stock | 2.19K | $206.62 | Direct | F2, F3 |
Id | Content |
---|---|
F1 | Represents the weighted average price of the shares sold ranging from a low of $469.00 to a high of $469.15 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
F2 | Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the one year anniversary of the date of grant or on the date of the 2019 annual meeting of shareholders, whichever event was earlier. |
F3 | Not applicable. |